What is the share price of Molbio Diagnostics Limited (MOLBIO) today?
The share price of MOLBIO as on 22nd October 2026 is ₹1259.70. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Molbio Diagnostics Limited (MOLBIO) share?
The past returns of Molbio Diagnostics Limited (MOLBIO) share are- Past 1 week: -13.87%
- Past 1 month: 2.23%
- Past 3 months: N/A%
- Past 6 months: 20.93%
- Past 1 year: 20.93%
- Past 3 years: N/A%
- Past 5 years: 20.93%
What are the peers or stocks similar to Molbio Diagnostics Limited (MOLBIO)?
The peers or stocks similar to Molbio Diagnostics Limited (MOLBIO) include:What is the market cap of Molbio Diagnostics Limited (MOLBIO) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Molbio Diagnostics Limited (MOLBIO) is ₹18143.38 Cr as of 22nd October 2026.What is the 52 week high and low of Molbio Diagnostics Limited (MOLBIO) share?
The 52-week high of Molbio Diagnostics Limited (MOLBIO) is ₹1686.80 and the 52-week low is ₹926.35.What is the PE and PB ratio of Molbio Diagnostics Limited (MOLBIO) stock?
The P/E (price-to-earnings) ratio of Molbio Diagnostics Limited (MOLBIO) is 108.90. The P/B (price-to-book) ratio is 13.86.Which sector does Molbio Diagnostics Limited (MOLBIO) belong to?
Molbio Diagnostics Limited (MOLBIO) belongs to the Health Care sector & Health Care Equipment & Supplies sub-sector.How to buy Molbio Diagnostics Limited (MOLBIO) shares?
You can directly buy Molbio Diagnostics Limited (MOLBIO) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Molbio Diagnostics Limited
MOLBIO Share Price
NSEMOLBIO Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
MOLBIO Performance & Key Metrics
MOLBIO Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| — | 13.86 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 44.18 | 5.54 | 0.51% |
from 3 analysts
Price Upside
Earnings Growth
Rev. Growth
MOLBIO Company Profile
Molbio Diagnostics Limited develops and manufactures chip-based diagnostic devices, reagents, and digital pathology solutions including Truenat PCR platform and ultraportable AI-powered X-Ray systems for infectious and non-infectious disease diagnostics.
MOLBIO Forecast
MOLBIO Forecasts
Price
Revenue
Earnings
MOLBIO Share Price Forecast
MOLBIO Share Price Forecast
All values in ₹
All values in ₹
MOLBIO Company Revenue Forecast
MOLBIO Company Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
MOLBIO Stock EPS (Earnings Per Share) Forecast
MOLBIO Stock EPS (Earnings Per Share) Forecast
All values in ₹
All values in ₹
MOLBIO
MOLBIO
Income
Balance Sheet
Cash Flow
MOLBIO Income Statement
MOLBIO Income Statement
| Quarter | jun 2025 | mar 2026 | jun 2026 | |||
|---|---|---|---|---|---|---|
| Total Revenue | 100.47 | 565.41 | 411.48 | |||
| Operating & Other expenses | 115.81 | 401.90 | 307.79 | |||
| EBITDA | -15.34 | 163.51 | 103.69 | |||
| Depreciation/Amortization | 12.32 | 19.60 | 17.08 | |||
| PBIT | -27.66 | 143.91 | 86.61 | |||
| Interest & Other Items | 3.61 | 12.08 | 10.70 | |||
| PBT | -31.27 | 131.83 | 75.91 | |||
| Taxes & Other Items | -7.56 | 41.01 | 17.17 | |||
| Net Income | -23.71 | 90.82 | 58.74 | |||
| EPS | -2.10 | 8.05 | 5.21 |
MOLBIO Company Updates
MOLBIO Stock Peers
MOLBIO Past Performance & Peer Comparison
MOLBIO Past Performance & Peer Comparison
Health CareHealth Care Equipment & Supplies
Valuation
Technical
Forecast
| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Molbio Diagnostics Limited | 108.90 | 13.86 | — |
| Inventurus Knowledge Solutions Ltd | 40.25 | 10.37 | — |
| Poly Medicure Limited | 50.15 | 5.13 | 0.22% |
| Fischer Medical Ventures Ltd | 64.32 | 5.38 | 0.02% |
MOLBIO Stock Price Comparison
Compare MOLBIO with any stock or ETFMOLBIO Holdings
MOLBIO Shareholdings
MOLBIO Promoter Holdings Trend
MOLBIO Promoter Holdings Trend
Pledged promoter holdings is insignificant
MOLBIO Institutional Holdings Trend
MOLBIO Institutional Holdings Trend
No institutional holdings trend are available
MOLBIO Shareholding Pattern
MOLBIO Shareholding Pattern
MOLBIO Shareholding History
MOLBIO Shareholding History
Mutual Funds Invested in MOLBIO
Mutual Funds Invested in MOLBIO
No mutual funds holding trends are available
Top 5 Mutual Funds holding Molbio Diagnostics Limited
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 1.9839% | Percentage of the fund’s portfolio invested in the stock 0.54% | Change in the portfolio weight of the stock over the last 3 months 0.54% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 75/78 (+2) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 1.6593% | Percentage of the fund’s portfolio invested in the stock 0.28% | Change in the portfolio weight of the stock over the last 3 months 0.28% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 79/89 (+10) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 1.0821% | Percentage of the fund’s portfolio invested in the stock 2.17% | Change in the portfolio weight of the stock over the last 3 months 2.17% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 114/141 (+18) |
Compare 3-month MF holding change on Screener
smallcases containing MOLBIO stock
smallcases containing MOLBIO stock
Looks like this stock is not in any smallcase yet.
MOLBIO Events
MOLBIO Events
MOLBIO Dividend Trend
MOLBIO has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
MOLBIO Dividend Trend
MOLBIO has not given any dividends in last 5 years
MOLBIO Dividends
MOLBIO Dividends
MOLBIO Stock News & Opinions
MOLBIO Stock News & Opinions
Molbio Diagnostics Limited informed the BSE Limited and National Stock Exchange of India Ltd that KFin Technologies Limited, its Registrar and Share Transfer Agent, has issued a certificate for the quarter ended September 30, 2026, as per Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming that the entire holding of the company was in electronic mode and no rematerialisation requests were received during the period.
Molbio Diagnostics Limited informed the BSE Limited and National Stock Exchange of India Ltd that the trading window for dealing in the company's securities will be closed for all insiders and designated persons and their immediate relatives from October 01, 2026, until 48 hours after the declaration of the unaudited financial results for the quarter ended September 30, 2026.
Molbio Diagnostics Limited informed the Bombay Stock Exchange and National Stock Exchange of India that its board of directors approved the re-appointment of M/s K. S. Kamalakara & Co, a Peer-reviewed firm with Firm Reg. No: 000296, as the Cost Auditors of the company for the financial year 2026-27.
Molbio Diagnostics Limited will hold a board meeting on September 5, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, as announced in a filing with the BSE Limited and National Stock Exchange of India Ltd. The trading window for the company's shares will remain closed from August 21, 2026, until 48 hours after the approval of the financial results.
Molbio Diagnostics Limited announced that its Board of Directors designated Mr. Darshan Raghunath Karekar as the Compliance Officer of the company under the SEBI (Prohibition of Insider Trading) Regulations, 2015, at a meeting held on August 27, 2026, which commenced at 04.56 P.M. and concluded at 05.08 P.M.
Molbio Diagnostics Limited informed the BSE Limited and National Stock Exchange of India Ltd that the trading window for dealing in the company's securities will be closed for all insiders and designated persons and their immediate relatives from August 21, 2026, until 48 hours after the declaration of the unaudited financial results for the quarter ended June 30, 2026.
Over the last 5 years, revenue has grown at a yearly rate of 2.76%, vs industry avg of 19.28%
Over the last 5 years, market share decreased from 30.83% to 12.21%
Over the last 5 years, net income has grown at a yearly rate of -18.65%, vs industry avg of 8.12%